Pharmacy Technology Selection Takes Center Stage in Upcoming Becker’s Webinar
Choosing a pharmacy technology partner is rarely a back-office decision alone. In health systems, ambulatory settings, and specialty pharmacy operations, the software and service relationship can shape medication access, workflow reliability, inventory control, prior authorization throughput, and the patient experience at the point where therapy either starts on time or stalls.
Becker’s Hospital Review is set to host a webinar titled “The questions to ask before choosing a pharmacy technology partner” on Thursday, December 3, from 12:00 PM to 1:00 PM CST. The session will feature Mel Nelson, PHARMD, CSP, vice president of specialty consulting services at Fairview Pharmacy Solutions, and Derrek Seif, chief strategy and product officer at VPL.
The timing fits a sector under constant pressure. Pharmacy teams are expected to move faster, reconcile more data streams, support more complex therapies, and reduce avoidable friction without adding avoidable burden to clinicians. Technology vendors now sit directly inside that equation, not on the margins of it.
Vendor Choice Has Become a Clinical Operations Decision
For many organizations, the first question is no longer whether pharmacy technology matters. It is which functions need to be solved first, and whether a vendor can support those priorities without forcing workarounds onto pharmacists, technicians, nurses, and prescribers.
Selection criteria often extend beyond a demonstration of features. Leaders must assess interoperability with existing systems, medication workflow design, support for specialty medications, visibility into status tracking, communication with patients and prescribers, and the durability of implementation support. In practice, a weak platform can create bottlenecks that delay dispensing, increase call volume, and fragment accountability across teams.
A strong platform does the opposite. It reduces manual repetition, improves traceability, and helps the pharmacy function as a coordinated clinical service rather than a series of disconnected tasks. The payoff reaches well beyond internal efficiency. When medication access is smoother, therapy initiation becomes more reliable, and patients are less likely to encounter delays that erode adherence before treatment even begins.
Specialty Pharmacy Raises the Stakes
The presence of a specialty pharmacy leader among the presenters is telling. Specialty workflows are often more complex than standard prescription fulfillment because they can require benefit investigation, adherence support, coordination with prescribers, and repeated status checks across multiple handoffs. A technology partner in that setting is not simply digitizing an order. It is helping manage a chain of clinical and administrative dependencies.
One missed handoff can slow therapy. One unclear status update can trigger a duplicate call. One poor interface can force staff to re-enter information that already exists elsewhere in the record. These are not abstract inefficiencies. They are the daily operational pressure points that determine whether a patient receives medication on schedule or waits while teams untangle process failures.
For systems managing high-cost or high-touch therapies, vendor selection also carries financial consequences. Rework consumes labor. Delays can increase abandonment risk. Fragmented data can impair reporting and make it harder to measure what is actually happening in the medication-use process. Technology partners therefore have to be evaluated not only for what they promise on a slide deck, but for how they behave when the volume rises and the workflow gets messy.
Questions Leaders Need Answered Before Signing a Contract
The webinar title points to a practical concern: the right questions are often more revealing than the product brochure. Pharmacy leaders typically need to know how a partner handles onboarding, how quickly the platform can be deployed, how service escalations are managed, and how well the company adapts to existing institutional processes instead of forcing a rigid template onto every site.
Equally important is whether the vendor understands medication operations as a clinical function. A technology company may know software architecture and still miss the realities of pharmacy staffing, prescriber communication, reimbursement complexity, and the documentation burden that shapes every transaction. When those operational realities are ignored, adoption suffers and the tool becomes another source of friction rather than a solution.
Questions about uptime, data integrity, reporting, and support structure matter because pharmacy services run on continuity. Even brief interruptions can ripple through dispensing, prior authorization work, and patient communication. A stable partner must therefore be judged on resilience, not only on feature count.
The session’s format suggests a discussion aimed at those exact issues. Rather than selling a single platform, the event is positioned around the decision framework itself, which is often where health systems need the most help. The right framework can separate a purchase that looks efficient on paper from one that actually improves day-to-day pharmacy performance.
Why Pharmacy Technology Choices Reach the Bedside
The impact of these decisions can be easy to miss if the conversation stays inside procurement language. In reality, pharmacy technology influences how quickly a medication order moves, how accurately staff can track a case, and how reliably a patient can be kept informed. Those are bedside consequences, even when the work starts in a command center or specialty hub.
The presenters’ backgrounds suggest a discussion grounded in both operational strategy and pharmacy practice. That combination is important because durable implementation depends on more than software knowledge. It requires an understanding of clinical priorities, workflow design, and the human labor behind every medication touchpoint.
Thursday’s webinar will likely draw attention from pharmacy executives, operations leaders, and administrators looking for a more disciplined way to evaluate technology vendors. The central issue is straightforward: if a partner cannot support the realities of pharmacy work, the system inherits the burden. If it can, the payoff may show up in smoother dispensing, better communication, and less wasted time chasing problems the software should have prevented in the first place.